Pharma-Bio Serv, Inc. (PBSV)

Pharma-Bio Serv Revenue

Pharma-Bio Serv had revenue of $2.34M in the quarter ending July 31, 2026, with 19.00% growth. This brings the company's total for the last twelve months to $9.48M, up 3.25% year-over-year. In the fiscal year ending October 31, 2025, Pharma-Bio Serv had annual revenue of $9.00M, down -5.34%. That makes Pharma-Bio Serv the 37,607th largest company in the world by revenue and 4,940th in the United States.

• Revenue (ttm): 9.48M
• Revenue Growth: +3.25%
• P/S Ratio: 1.09
• Revenue / Employee: 172.43K
• Employees: 55
• Market Cap: 10.31M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Puerto Rico Consulting 4.64M 51.5%
• United States Consulting 2.62M 29.1%
• Europe Consulting 1.73M 19.2%
• Other 16.67K 0.2%

By Geography

Chart

• Puerto Rico 4.64M 51.5%
• United States 2.62M 29.1%
• Europe 1.73M 19.2%
• Other 17.00K 0.2%

Fiscal year ended Oct 31, 2025 See the full Pharma-Bio Serv breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2025	9.00M	-508.18K	-5.34%
Oct 31, 2024	9.51M	-7.47M	-43.99%
Oct 31, 2023	16.98M	-2.42M	-12.48%
Oct 31, 2022	19.40M	-716.45K	-3.56%
Oct 31, 2021	20.12M	-1.45M	-6.72%

Data Source: S&P Global Market Intelligence Last updated: Sep 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error